UPDATED: Researchers home in on breast cancer biomarker

Researchers at the Maine Medical Center Research Institute have discovered a potential cancer biomarker by detecting a specific protein in patients' blood. While the protein was first suspected to be a breast cancer biomarker, researchers have found elevated levels in skin, prostate and lung cancer patients as well. The biomarker, osteopontin, is a tumor antigen.

"Normally there is not a lot of this circulating in our blood, but when cancer occurs, the tumor cells start to make a variety of proteins that are abnormal and the biomarker is one of these proteins," said Lucy Liaw, a research scientist at the institute studying the biomarker.

Liaw and her colleagues hope that the biomarker could be used for early cancer detection, especially in patients with a high risk of developing breast cancer, thanks to a diagnostic test they are working on.

- check out the WLBZ story and video

Editor's note: This story was updated to include the name of the biomarker under investigation in Liaw's lab.

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.